One of the ARK exchange-traded funds run by ETF star Cathie Wood made huge sale on Wednesday. This fund sold over 125,000 shares of Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares, as the price of this ETF was flat on Wednesday. Note that this ETF is still up handily in the past year.
ARK Innovation ETF (NYSEARCA: ARKK) sold 128,163 shares of Iovance. At Wednesday’s closing price, this would have valued this sale at $3 million. Even though this is a small fraction of the total holdings, every little bit counts. The fund is up 37% in the past year.
Check out all of the ARK Invest sales for Wednesday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | 3690HK | MEITUAN | 1,342,426 |
| ARKF | 9923HK | YEAHKA | 339,600 |
| ARKF | 6060HK | ZHONGAN ONLINE P&C INSURANCE | 1,339,400 |
| ARKG | SEER | SEER | 152,557 |
| ARKG | RHHBY | ROCHE | 66,000 |
| ARKG | PSTI | PLURISTEM THERAPEUTICS | 16,223 |
| ARKG | BMY | BRISTOL-MYERS SQUIBB | 114,400 |
| ARKK | IOVA | IOVANCE BIOTHERAPEUTICS | 128,163 |
| ARKK | NTDOY | NINTENDO | 53,300 |
| ARKQ | XONE | EXONE | 82,333 |
| ARKW | LC | LENDINGCLUB | 164,932 |
| ARKW | NFLX | NETFLIX | 192 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
